Glycorex Transplantation AB

Glycorex Transplantation AB (publ.) develops products that decrease the risk of graft-rejection. The products facilitate an increased number of transplants. The company develops products within three areas: Allotransplantation (man to man), Xenotransplantation (animal to man), Products for development of universal blood-plasma.
In the development of its products the company is using a unique biotechnology platform based on carbohydrate technology.
Manufactures research quantities and large scale quantities of bioactive carbohydrates, neoglycoconjugates, reagents and affinity materials for research and commercial applications. Bioactive Carbohydrates-Examples of Applications: Food additives, Cancer, Infectious diseases, Transplantation and Inflammation.Custom Synthesis-Large Scale Enzymatic Synthesis.
Stock-exchange (NGM EQUITY) Glycorex Transplantation AB is listed as GTAB

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Reagents
- Technology

Therapeutic targets:

- Surgery
- Transplant

Markets Covered

a. HeadQuarter: Sweden

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: 1996